Allison Testroet, DO
Family Medicine · Huxley, IANPI 1568421873
Payments from drug & device makers
Across 298 payments — averaging $14.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$779
- Novo Nordisk$523
- Boehringer Ingelheim$522
- Johnson & Johnson$376
- GSK$274
- Biohaven Pharmaceutical Holding Company Ltd.$234
- plus $2K from 23 others
What the payments were for
- Food & beverage$4,316100%
- Education$150%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 67 | $779 |
| Novo Nordisk | 35 | $523 |
| Boehringer Ingelheim | 33 | $522 |
| Johnson & Johnson | 29 | $376 |
| GSK | 19 | $274 |
| Biohaven Pharmaceutical Holding Company Ltd. | 16 | $234 |
| Amgen | 13 | $221 |
| Novartis | 13 | $209 |
| Merck | 10 | $143 |
| Abbott | 5 | $112 |
| Pfizer | 7 | $111 |
| Astellas Pharma US Inc | 8 | $105 |
| AstraZeneca | 7 | $102 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $102 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $74 |
| Bristol Myers Squibb | 4 | $59 |
| E.r. Squibb & Sons, L.L.C. | 3 | $52 |
| Lilly USA, LLC | 3 | $50 |
| Therapeuticsmd, Inc. | 3 | $47 |
| Kowa Pharmaceuticals America, Inc. | 3 | $39 |
| Bayer | 2 | $39 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
| Idorsia Pharmaceuticals US Inc | 1 | $23 |
| Genentech USA, Inc. | 1 | $20 |
| Kaleo, Inc. | 1 | $20 |
| Pacira Therapeutics, Inc. | 1 | $20 |
| Ultragenyx Pharmaceutical Inc. | 1 | $17 |
| Avanir Pharmaceuticals, Inc. | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $14 |
How this compares
$4,330 in reported general payments places this provider in the 90th percentile of 1,357 family medicine providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 46 | $63,242 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 40 | $38,302 |
| JardianceEmpagliflozin | 32 | $35,564 |
| TrulicityDulaglutide | 21 | $26,170 |
| EliquisApixaban | 15 | $23,001 |
| XareltoRivaroxaban | 18 | $12,429 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 24 | $10,739 |
| JanuviaSitagliptin Phosphate | 11 | $9,114 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 14 | $4,165 |
| Levothyroxine Sodium | 301 | $2,367 |
| Gabapentin | 92 | $1,712 |
| Omeprazole | 145 | $1,685 |
| Duloxetine Hcl | 41 | $1,401 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 46 | $1,121 |
| Bupropion XlBupropion Hcl | 32 | $1,053 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $523 | $63,24246 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $274 | $49,04164 claims |
| Boehringer IngelheimJardiance | $522 | $35,56432 claims |
| Lilly USA, LLCTrulicity | $50 | $26,17021 claims |
| PfizerEliquis | $111 | $23,00115 claims |
| Johnson & JohnsonXarelto | $376 | $12,42918 claims |
| MerckJanuvia | $143 | $9,11411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,357 family medicine providers in Iowa.
Other family medicine in Huxley
- Kirk PetersonHuxley$576K
- Nicholas GoetschWaterloo$4.1M
- James PoockWaterloo$1.5M
- Jennifer KayCouncil Bluffs$613K
- Nicholas BechtoldSioux City$584K
- Stephen HarrisonClinton$249K
- Sharon SteenBelle Plaine$241K
- Carlos Alarcon SchroderJohnston$237K
- Thomas RossDes Moines$170K
- Yogesh ShahDes Moines$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.